Franklin Resources’s Global Blood Therapeutics GBT Stock Holding History
Bought
Maintained
Sold
Other funds holding GBT
BBA
Franklin Resources's GBT Position: Q3 2022 in Review
Franklin Resources sold out of Global Blood Therapeutics (GBT) in Q3 2022, closing a stake of 469,444 shares — an estimated $15M sold.
Franklin Resources first reported a position in GBT in Q1 2018 and held it in 18 quarters. The position peaked at $106M in Q3 2020. 247 funds tracked by Wall St. Rank hold GBT as of Q3 2022.
- Franklin Resources reported no remaining Global Blood Therapeutics position as of Q3 2022 after selling out during the quarter.
- Franklin Resources sold 469,444 Global Blood Therapeutics shares in Q3 2022, an estimated $15M.
- Franklin Resources first reported a position in Global Blood Therapeutics in Q1 2018 and held it in 18 quarters.
- Franklin Resources's Global Blood Therapeutics position peaked at $106M in Q3 2020.
- 247 funds tracked by Wall St. Rank held Global Blood Therapeutics as of Q3 2022.
Based on Franklin Resources's 13F filing for Q3 2022, filed 14 Nov 2022.